Antimicrobials, anti-inflammatories, and vaccines were associated with reduced dementia risk, while antipsychotics, antidepressants, and diabetes medications were frequently associated with increased dementia risk.
Study of 9846 older adults shows higher total cholesterol and LDL-c variability associated with increased dementia risk and accelerated cognitive decline over a 5.8-year follow-up, independent of mean lipid levels.
FDA designates novel plasma-based Alzheimer's biomarker assay for accelerated review, potentially offering clinicians a less invasive diagnostic alternative to current standards of care.